Xcout IntelSign inSubscribe

CERYVYN THERAPEUTICS LIMITED

CYVPharmaceuticals, Biotechnology & Life SciencesMelbourne, Australia

Ceryvyn Therapeutics Limited, a clinical-stage biopharmaceutical company, researches and develops therapeutic products based on targeting vascular endothelial growth factors (VEGF) C, D and R3 in Australia and the United States. The company's pipeline includes Sozinibercept, which is in phase 3 to treat wet age-related macular degeneration (Wet AMD), as well as in phase 2 to treat diabetic macular edema (DME). It serves the biotechnology and healthcare industries. The company was formerly known as Opthea Limited and changed its name to Ceryvyn Therapeutics Limited in July 2026. Ceryvyn Therapeutics Limited was incorporated in 1984 and is headquartered in Melbourne, Australia.

Subscribe to see CERYVYN THERAPEUTICS LIMITED’s full profile → the full roster, investors in every round, weekly hiring history and every corporate event

CERYVYN THERAPEUTICS LIMITED at a glance

CERYVYN THERAPEUTICS LIMITED is a pharmaceuticals, biotechnology & life sciences company headquartered in Melbourne, Australia. It is publicly listed (CYV) with a market capitalisation of $10.7M. Xcout tracks 8 named people at CERYVYN THERAPEUTICS LIMITED, including Jeremy M Levin (Executive Chair and CEO).

Industry
Pharmaceuticals, Biotechnology & Life Sciences
Headquarters
Melbourne, Australia
Market cap
$10.7M
Employees
10
Ticker
CYV

CERYVYN THERAPEUTICS LIMITED leadership

  • Jeremy M LevinExecutive Chair and CEO
  • Stuart MudgeChief Operating Officer
  • Hamish GeorgeChief Financial Officer & Company Secretary
  • Mike GeromettaChief Technology Officer
  • Rebbecca WilcoxSenior Vice President, Preclinical and Translational Science
  • Megan BrennanGeneral Manager

2 more named people on record for CERYVYN THERAPEUTICS LIMITED, with roles, board committees and tenure — see the full roster →

Get CERYVYN THERAPEUTICS LIMITED's news by email

Funding rounds, acquisitions, new executives, launches and expansions, each with a two-line summary and a link to the source. One short email a day, only when there is news.

Free: up to 5 companies, daily. Subscribers also follow whole sectors and saved filters (M&A in Israel, AI funding…), get instant alerts, in-app notifications and signed webhooks, and open the full profile behind every name. Subscribe →

Share this card

Post the link and the card appears automatically — each network fetches the image itself.

CERYVYN THERAPEUTICS LIMITED — share card preview

Instagram, TikTok and Slack canvases don't expand links — download the card as a PNG and post it as an image instead.

More on CERYVYN THERAPEUTICS LIMITED in Xcout Intel

  • 8 named people with titles, LinkedIn and board committees
  • The full competitor set, tracking, exports and API access
Subscribe to Xcout Intel →